Literature DB >> 8983960

Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.

J X Ma1, Q Song, H C Hatcher, R K Crouch, L Chao, J Chao.   

Abstract

Tissue kallikrein is a serine proteinase which processes kininogens to release bioactive kinins. Kinins mediate a variety of biological processes through the interaction with kinin receptors. Kinins are involved in the regulation of blood pressure and local blood flow, vasodilation, smooth muscle contraction and relaxation, production of pain and inflammation, and stimulation of cell proliferation. The tissue kallikrein-kinin system has been implicated in a number of pathophysiological processes such as hypertension, allergy and diabetes mellitus. In the present study, we have identified the expression and localization of components of the kallikrein-kinin system in the human eye by reverse transcription-polymerase chain reaction (RT-PCR) and Southern blot analyses, and in situ hybridization histochemistry. RT-PCR and Southern blot analyses have detected mRNAs of the key components of the system including tissue kallikrein, low molecular weight kininogen, and bradykinin B1 and B2 receptors at high levels in human retina, choroid and ciliary body, and relatively low levels in the optic nerve. In situ hybridization has identified cellular localization of these four mRNAs in ocular tissues. They are expressed in retinal neuronal cells including the outer nuclear layer, inner nuclear layer and ganglion cell layer. These mRNAs were also identified in endothelial cells of ocular blood vessels, ciliary muscle and lens epithelial cells. The sense riboprobes showed negative staining, which indicates the specificity of the antisense riboprobes. These results suggest that the tissue kallikrein-kinin system is produced endogenously in human ocular tissues. Similar expression patterns of kallikrein, kininogen and kinin receptors indicate that the kallikrein-kinin system may function in an autocrine or paracrine fashion in the eye.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8983960     DOI: 10.1006/exer.1996.0087

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  24 in total

1.  Plasma kallikrein and diabetic macular edema.

Authors:  Edward P Feener
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

2.  Expression of the kallikrein/kinin system in human anterior segment.

Authors:  Jerry G Webb; Xiaofeng Yang; Craig E Crosson
Journal:  Exp Eye Res       Date:  2009-03-04       Impact factor: 3.467

Review 3.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

4.  Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects.

Authors:  D deBlois; R A Horlick
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.

Authors:  Takeshi Kita; Allen C Clermont; Nivetha Murugesan; Qunfang Zhou; Kimihiko Fujisawa; Tatsuro Ishibashi; Lloyd Paul Aiello; Edward P Feener
Journal:  Diabetes       Date:  2015-05-15       Impact factor: 9.461

6.  Expression, distribution and function of kinin B1 receptor in the rat diabetic retina.

Authors:  Soumaya Hachana; Menakshi Bhat; Jacques Sénécal; Frédéric Huppé-Gourgues; Réjean Couture; Elvire Vaucher
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

7.  Bradykinin activation of extracellular signal-regulated kinases in human trabecular meshwork cells.

Authors:  Jerry G Webb; Xiaofeng Yang; Craig E Crosson
Journal:  Exp Eye Res       Date:  2011-03-21       Impact factor: 3.467

8.  Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.

Authors:  Robert F Mullins; Elizabeth A Faidley; Heather T Daggett; Catherine Jomary; Andrew J Lotery; Edwin M Stone
Journal:  Exp Eye Res       Date:  2009-07-14       Impact factor: 3.467

9.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

10.  Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat.

Authors:  Mohamed Abdouh; Ashraf Khanjari; Nadia Abdelazziz; Brice Ongali; Réjean Couture; Haroutioun M Hasséssian
Journal:  Br J Pharmacol       Date:  2003-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.